Lv3
374 积分 2024-09-18 加入
The safety and feasibility of same-day discharge for the management of patients undergoing pulmonary lobectomy
12小时前
待确认
The safety and feasibility of same-day discharge for the management of patients undergoing pulmonary lobectomy
12小时前
已关闭
The safety and feasibility of same-day discharge for the management of patients undergoing pulmonary lobectomy
12小时前
已关闭
The safety and feasibility of same-day discharge for the management of patients undergoing pulmonary lobectomy
12小时前
已关闭
CAR-T therapy in solid tumors
18天前
已完结
CAR-T therapy in solid tumors
20天前
已完结
CAR T cell immunotherapy for human cancer
20天前
已完结
The next generation of immunotherapies for lung cancers
2个月前
已完结
Cancer immunoediting: from immunosurveillance to tumor escape
2个月前
已完结
Comparison of the efficacy and safety of domestically produced tislelizumab, camrelizumab, and imported pembrolizumab in the treatment of advanced NSCLC: a real-world retrospective study
4个月前
已完结
皖公网安备34019202002308
